Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,586 | -78,485 | 59,337 | -54,789 | -6,597 |
| Depreciation Amortization | 1,511 | 2,376 | 1,623 | 1,021 | 970 |
| Accounts payable and accrued liabilities | -1,301 | -226 | -2,716 | 583 | 23 |
| Other Working Capital | -7,588 | 2,109 | -42,329 | -14,252 | -12,826 |
| Other Operating Activity | 11,412 | 11,882 | 14,082 | 7,297 | 5,208 |
| Operating Cash Flow | $-59,552 | $-62,344 | $29,997 | $-60,140 | $-13,222 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -497 | -120 | -43 | -1,538 | -2,019 |
| Purchase Of Investment | -40,191 | -111,632 | -650 | -118,347 | -107,257 |
| Sale Of Investment | 63,445 | 12,500 | 59,000 | 136,850 | 72,692 |
| Investing Cash Flow | $22,757 | $-99,252 | $58,307 | $16,965 | $-36,584 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,687 | 10,000 | 7,217 | N/A |
| Common Stock Issued | 31,660 | 31,813 | 30,082 | 279 | 112,407 |
| Other Financing Activity | 0 | 0 | 0 | -81 | -2,031 |
| Financing Cash Flow | $31,660 | $42,500 | $40,082 | $7,415 | $110,376 |
| Beginning Cash Position | 57,640 | 176,736 | 48,350 | 84,110 | 23,540 |
| End Cash Position | 52,505 | 57,640 | 176,736 | 48,350 | 84,110 |
| Net Cash Flow | $-5,135 | $-119,096 | $128,386 | $-35,760 | $60,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,552 | -62,344 | 29,997 | -60,140 | -13,222 |
| Capital Expenditure | -497 | -120 | -43 | -1,538 | -2,019 |
| Free Cash Flow | -60,049 | -62,464 | 29,954 | -61,678 | -15,241 |